Genesis Biosciences to trial biogas additive with United Utilities
Genesis Biosciences, based in Wales, UK, has been chosen to take part in United Utilities’ exclusive Innovation Lab, which provides successful applicants the chance to test their products in a live environment before going to market.
The firm will be trialling its Evogen Biogas Additive – a powdered product that combines a novel mineral carrier with an application-specific, naturally-occurring, non-pathogenic, stable microbial component. The application of the Evogen Biogas Additive can contribute towards the circular economy of sludge treatment and disposal through delivering improvements across the entire system of treating and disposing of sludge.
United Utilities manages the water and wastewater services in the North West of England, delivering 1.8 billion litres of water a day to more than 3 million homes and businesses, as well as treating all the wastewater. Its Innovation Lab is focussed on providing the most efficient and sustainable working practices and allows both start-up and established companies a live operational environment to learn and develop potential ideas and solutions.
The 12-week programme began on 25 January, with a mid-point review in March, and a final demonstration day on 12 April explaining the outcomes of each trial. Finalists will have access to mentorship, data, and insights throughout the project as well as gaining access to, and building relationships with, senior United Utilities executives with the potential to lead to longer-term commercial partnerships.
Emma Saunders, general manager at Genesis Biosciences, said: “This is a very exciting project to be involved in. We have worked with United Utilities in the past, but this particular programme will allow us to specifically sample our Evogen Biogas Additive in a live setting and grow our relationship with the organisation at the same time. We look forward to seeing how the trial progresses and reviewing the results.”
Successful trials could see the early technology being rolled out across the UK and Europe.
The firm will be trialling its Evogen Biogas Additive – a powdered product that combines a novel mineral carrier with an application-specific, naturally-occurring, non-pathogenic, stable microbial component. The application of the Evogen Biogas Additive can contribute towards the circular economy of sludge treatment and disposal through delivering improvements across the entire system of treating and disposing of sludge.
United Utilities manages the water and wastewater services in the North West of England, delivering 1.8 billion litres of water a day to more than 3 million homes and businesses, as well as treating all the wastewater. Its Innovation Lab is focussed on providing the most efficient and sustainable working practices and allows both start-up and established companies a live operational environment to learn and develop potential ideas and solutions.
The 12-week programme began on 25 January, with a mid-point review in March, and a final demonstration day on 12 April explaining the outcomes of each trial. Finalists will have access to mentorship, data, and insights throughout the project as well as gaining access to, and building relationships with, senior United Utilities executives with the potential to lead to longer-term commercial partnerships.
Emma Saunders, general manager at Genesis Biosciences, said: “This is a very exciting project to be involved in. We have worked with United Utilities in the past, but this particular programme will allow us to specifically sample our Evogen Biogas Additive in a live setting and grow our relationship with the organisation at the same time. We look forward to seeing how the trial progresses and reviewing the results.”
Successful trials could see the early technology being rolled out across the UK and Europe.
